Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sodium‐glucose Cotransporter (SGLT) 2 Inhibitors for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Risk for the Development of Type 2 Diabetes Mellitus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435527/all/Sodium‐glucose_cotransporter__SGLT__2_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_risk_for_the_development_of_type_2_diabetes_mellitus. Accessed 19 September 2024.
Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435527/all/Sodium‐glucose_cotransporter__SGLT__2_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_risk_for_the_development_of_type_2_diabetes_mellitus. Accessed September 19, 2024.
Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435527/all/Sodium‐glucose_cotransporter__SGLT__2_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_risk_for_the_development_of_type_2_diabetes_mellitus
Sodium‐glucose Cotransporter (SGLT) 2 Inhibitors for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Risk for the Development of Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. [cited 2024 September 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435527/all/Sodium‐glucose_cotransporter__SGLT__2_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_risk_for_the_development_of_type_2_diabetes_mellitus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
ID - 435527
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435527/all/Sodium‐glucose_cotransporter__SGLT__2_inhibitors_for_prevention_or_delay_of_type_2_diabetes_mellitus_and_its_associated_complications_in_people_at_risk_for_the_development_of_type_2_diabetes_mellitus
DB - Evidence Central
DP - Unbound Medicine
ER -